DEFEROXAMINE Drug Patent Profile
✉ Email this page to a colleague
When do Deferoxamine patents expire, and when can generic versions of Deferoxamine launch?
Deferoxamine is a drug marketed by Dr Reddys, Fresenius Kabi Usa, Gland, Hikma, and Hospira. and is included in five NDAs.
The generic ingredient in DEFEROXAMINE is deferoxamine mesylate. There are seven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the deferoxamine mesylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Deferoxamine
A generic version of DEFEROXAMINE was approved as deferoxamine mesylate by HOSPIRA on March 17th, 2004.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DEFEROXAMINE?
- What are the global sales for DEFEROXAMINE?
- What is Average Wholesale Price for DEFEROXAMINE?
Summary for DEFEROXAMINE
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 5 |
| Drug Prices: | Drug price information for DEFEROXAMINE |
| DailyMed Link: | DEFEROXAMINE at DailyMed |
US Patents and Regulatory Information for DEFEROXAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dr Reddys | DEFEROXAMINE MESYLATE | deferoxamine mesylate | INJECTABLE;INJECTION | 076806-002 | Mar 31, 2006 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hikma | DEFEROXAMINE MESYLATE | deferoxamine mesylate | INJECTABLE;INJECTION | 078086-002 | May 30, 2007 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Fresenius Kabi Usa | DEFEROXAMINE MESYLATE | deferoxamine mesylate | INJECTABLE;INJECTION | 078718-001 | Sep 15, 2009 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
